MiR-19b-1 inhibits angiogenesis by blocking cell cycle progression of endothelial cells

Biochemical and Biophysical Research Communications

Volumn 417, Issue 2, 2012, Pages 771-776

  Yin, Runting ^a,b   Bao, Weiwei ^b   Xing, Yingying ^b   Xi, Tao ^b   Gou, Shaohua ^a  

^a SOUTHEAST UNIVERSITY   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Angiogenesis; Cell cycle; FGFR2; MicroRNAs; MiR 19b 1; S phase

Indexed keywords

CYCLIN D1; FIBROBLAST GROWTH FACTOR RECEPTOR 2; MESSENGER RNA; MICRORNA; MICRORNA 19B 1; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANTIGEN EXPRESSION; ARTICLE; CELL CYCLE CHECKPOINT; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE CLUSTER; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; UMBILICAL VEIN ENDOTHELIAL CELL;

CELL CYCLE; CELL PROLIFERATION; ENDOTHELIAL CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MICRORNAS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2;

EID: 84855859228     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.12.032     Document Type: Article

References (26)

1. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
2. Zhao Y., Ransom J.F., Li A., Vedantham V., von Drehle M., Muth A.N., Tsuchihashi T., McManus M.T., Schwartz R.J., Srivastava D. Dysregulation of Cardiogenesis, Cardiac Conduction, and Cell Cycle in Mice Lacking miRNA-1-2. Cell 2007, 129:303-317.
3. Esquela-Kerscher A., Slack F.J. Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer 2006, 6:259-269.
4. Giraldez A.J., Cinalli R.M., Glasner M.E., Enright A.J., Thomson J.M., Baskerville S., Hammond S.M., Bartel D.P., Schier A.F. MicroRNAs regulate brain morphogenesis in zebrafish. Science 2005, 308:833-838.
5. Kuehbacher A., Urbich C., Zeiher A.M., Dimmeler S. Role of Dicer and Drosha for endothelial microrna expression and angiogenesis. Circ. Res. 2007, 101:59-68.
6. Poliseno L., Tuccoli A., Mariani L., Evangelista M., Citti L., Woods K., Mercatanti A., Hammond S., Rainaldi G. MicroRNAs modulate the angiogenic properties of HUVECs. Blood 2006, 108:3068-3071.
7. Hua Z., Lv Q., Ye W., Wong C.-K.A., Cai G., Gu D., Ji Y., Zhao C., Wang J., Yang B.B., Zhang Y. MiRNA-Directed Regulation of VEGF and Other Angiogenic Factors under Hypoxia. PLoS ONE 2006, 1:e116.
8. O'Donnell K.A., Wentzel E.A., Zeller K.I., Dang C.V., Mendell J.T. C-Myc-regulated microRNAs modulate E2F1 expression. Nature 2005, 435:839-843.
9. Mestdagh P., Bostrom A.K., Impens F., Fredlund E., Van Peer G., De Antonellis P., von Stedingk K., Ghesquiere B., Schulte S., Dews M., Thomas-Tikhonenko A., Schulte J.H., Zollo M., Schramm A., Gevaert K., Axelson H., Speleman F., Vandesompele J. The miR-17-92 microRNA cluster regulates multiple components of the TGF-beta pathway in neuroblastoma. Mol. Cell 2010, 40:762-773.
10. Dews M., Homayouni A., Yu D., Murphy D., Sevignani C., Wentzel E., Furth E.E., Lee W.M., Enders G.H., Mendell J.T., Thomas-Tikhonenko A. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat. Genet. 2006, 38:1060-1065.
11. Dews M., Fox J.L., Hultine S., Sundaram P., Wang W., Liu Y.Y., Furth E., Enders G.H., El-Deiry W., Schelter J.M., Cleary M.A., Thomas-Tikhonenko A. The myc-miR-17 92 axis blunts TGF{beta} signaling and production of multiple TGF{beta}-dependent antiangiogenic factors. Cancer Res. 2010, 70:8233-8246.
12. Kuhnert F., Kuo C.J. MiR-17-92 angiogenesis micromanagement. Blood 2010, 115:4631-4633.
13. Wu F., Yang Z., Li G. Role of specific microRNAs for endothelial function and angiogenesis. Biochem. Biophys. Res. Commun. 2009, 386:549-553.
14. Venturini L., Battmer K., Castoldi M., Schultheis B., Hochhaus A., Muckenthaler M.U., Ganser A., Eder M., Scherr M. Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells. Blood 2007, 109:4399-4405.
15. Olive V., Jiang I., He L. Mir-17-92, a cluster of miRNAs in the midst of the cancer network. Int. J. Biochem. Cell Biol. 2010, 42:1348-1354.
16. Cloonan N., Brown M.K., Steptoe A.L., Wani S., Chan W.L., Forrest A.R., Kolle G., Gabrielli B., Grimmond S.M. The miR-17-5p microRNA is a key regulator of the G1/S phase cell cycle transition. Genome Biol. 2008, 9:R127.
17. Pickering M.T., Stadler B.M., Kowalik T.F. MiR-17 and miR-20a temper an E2F1-induced G1 checkpoint to regulate cell cycle progression. Oncogene 2009, 28:140-145.
18. Inomata M., Tagawa H., Guo Y.M., Kameoka Y., Takahashi N., Sawada K. MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes. Blood 2009, 113:396-402.
19. Fontana L., Fiori M.E., Albini S., Cifaldi L., Giovinazzi S., Forloni M., Boldrini R., Donfrancesco A., Federici V., Giacomini P., Peschle C., Fruci D. Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM. PLoS ONE 2008, 3:e2236.
20. Bonauer A., Carmona G., Iwasaki M., Mione M., Koyanagi M., Fischer A., Burchfield J., Fox H., Doebele C., Ohtani K., Chavakis E., Potente M., Tjwa M., Urbich C., Zeiher A.M., Dimmeler S. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 2009, 324:1710-1713.
21. Olive V., Bennett M.J., Walker J.C., Ma C., Jiang I., Cordon-Cardo C., Li Q.J., Lowe S.W., Hannon G.J., He L. MiR-19 is a key oncogenic component of mir-17-92. Genes Dev. 2009, 23:2839-2849.
22. Jaffe E.A., Nachman R.L., Becker C.G., Minick C.R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest. 1973, 52:2745-2756.
23. Lee O.H., Kim Y.M., Lee Y.M., Moon E.J., Lee D.J., Kim J.H., Kim K.W., Kwon Y.G. Sphingosine 1-phosphate induces angiogenesis: its angiogenic action and signaling mechanism in human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun. 1999, 264:743-750.
24. Papetti M., Herman I.M. Mechanisms of normal and tumor-derived angiogenesis. Am. J. Physiol. - Cell Physiol. 2002, 282:C947-C970.
25. Liang J., Slingerland J.M. Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell Cycle 2003, 2:336-342.
26. Dennis W S. Cyclin D1 serves as a cell cycle regulatory switch in actively proliferating cells. Curr. Opin. Cell Biol. 2003, 15:158-163.